Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
asunaprevir (1 trial)
daclatasvir (daklinza) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
ribavirin (virazole) (1 trial)
Hepatitis (Phase 2)
Hepatitis C (Phase 2)
Trials (1 total)
Trial APIs (4 total)